Effects of miglitol on glucose metabolism and gut-derived hormones in type 2 diabetes who lose response to sitaglipti
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000013244
- Lead Sponsor
- Hyogo college of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Not provided
1. Patients with serious heart, liver, kidney diseases 2. Pregnant and/or breathbeeding, child-bearing potential women. 3. Patients who is complicated with a malignant tumor 4. Patients with severe infection, perioperative, severe injury 5. Patients who are undergoing treatment with an arufa-glucosidase inhibitor or a rapid-acting insulin secretagogue 6. Other patients whom their physicians in charge considered unsuitable for inclusion in this study a. Patients who has laparotomy or ileus b. Patients with chronic bowel diseases with malabsorption c. Patients who has the disease which is deteriorated with increase of gas in bowel d. Patients with intolerance in Lactose e. Patient with diabetic retinopathy to need photocoagulation or vitreous surgery f. Patients with serious diabetic complications including progressed neutopathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method plasma glucose, HbA1c, GA, 1,5-AG,Peptide, active GLP-1, and body weight
- Secondary Outcome Measures
Name Time Method